Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-04 09:12 am Purchase | 13G | AKERO THERAPEUTICS INC AKRO | WELLINGTON MANAGEMENT GROUP LLP | 1,876,811 5.38% | 1,876,811 (New Position) | View |
| 2021-12-13 4:58 pm Purchase | 13G | AKERO THERAPEUTICS INC AKRO | Point72 Asset Management L.P. | 1,751,563 5% | 1,751,563 (New Position) | View |
| 2021-06-30 4:17 pm Purchase | 13G | AKERO THERAPEUTICS INC AKRO | Skorpios Trust | 4,907,829 14.1% | 4,907,829 (New Position) | View |
| 2021-06-28 8:56 pm Sale | 13D | AKERO THERAPEUTICS INC AKRO | ATP Life Science Ventures L.P. | 674,640 1.9% | -5,164,229 (-88.45%) | View |
| 2021-05-07 4:13 pm Sale | 13D | AKERO THERAPEUTICS INC AKRO | venBio Global Strategic Fund II L.P. | 2,315,893 6.65% | -352,824 (-13.22%) | View |
| 2021-02-16 5:27 pm Sale | 13G | AKERO THERAPEUTICS INC AKRO | Atlas Venture Fund XI L.P. | 2,206,412 6.4% | -500,000 (-18.47%) | View |
| 2021-02-16 4:05 pm Purchase | 13G | AKERO THERAPEUTICS INC AKRO | Redmile Group LLC | 2,322,557 6.69% | 2,322,557 (New Position) | View |
| 2021-02-12 8:41 pm Sale | 13G | AKERO THERAPEUTICS INC AKRO | Versant Venture Capital VI L.P. | 777,727 2.2% | -2,878,858 (-78.73%) | View |
| 2021-02-11 4:54 pm Purchase | 13G | AKERO THERAPEUTICS INC AKRO | ALKEON CAPITAL MANAGEMENT LLC | 2,287,630 6.6% | 2,287,630 (New Position) | View |
| 2021-02-11 3:50 pm Sale | 13G | AKERO THERAPEUTICS INC AKRO | JANUS HENDERSON GROUP PLC JHG | 3,493,419 10.1% | -13,809 (-0.39%) | View |
| 2021-02-05 4:35 pm Sale | 13G | AKERO THERAPEUTICS INC AKRO | AMGEN INC AMGN | 1,508,375 4.344% | -397,323 (-20.85%) | View |
| 2020-09-10 2:14 pm Purchase | 13G | AKERO THERAPEUTICS INC AKRO | JANUS HENDERSON GROUP PLC JHG | 3,507,228 10.1% | 1,097,695 (+45.56%) | View |
| 2020-09-09 5:26 pm Sale | 13D | AKERO THERAPEUTICS INC AKRO | venBio Global Strategic Fund II L.P. | 2,668,717 7.7% | -653,421 (-19.67%) | View |
| 2020-07-14 5:06 pm Purchase | 13D | AKERO THERAPEUTICS INC AKRO | ATP Life Science Ventures L.P. | 5,838,869 17.2% | 423,666 (+7.82%) | View |
| 2020-07-08 3:54 pm Purchase | 13D | AKERO THERAPEUTICS INC AKRO | venBio Global Strategic Fund L.P. | 3,033,552 10.6% | 3,033,552 (New Position) | View |
| 2020-02-14 3:46 pm Purchase | 13G | AKERO THERAPEUTICS INC AKRO | JANUS HENDERSON GROUP PLC JHG | 2,409,533 8.4% | 2,409,533 (New Position) | View |
| 2020-02-14 11:07 am Sale | 13G | AKERO THERAPEUTICS INC AKRO | Versant Venture Capital VI L.P. | 3,656,585 12.8% | -448,273 (-10.92%) | View |
| 2020-02-13 5:00 pm Purchase | 13G | AKERO THERAPEUTICS INC AKRO | Atlas Venture Fund XI L.P. | 2,706,412 9.5% | 2,706,412 (New Position) | View |
| 2020-02-07 7:37 pm Purchase | 13G | AKERO THERAPEUTICS INC AKRO | AMGEN INC AMGN | 1,905,698 6.67% | 1,905,698 (New Position) | View |
| 2020-01-15 4:27 pm Sale | 13D | AKERO THERAPEUTICS INC AKRO | venBio Global Strategic Fund II L.P. | 3,322,138 11.6% | -632,720 (-16.00%) | View |